Jeffrey S. Chamberlain

Also affiliated with University of Washington

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects”.

Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects

PLoS Genetics(2020)10.1371/journal.pgen.1009179

N/A

0DataRank · unranked

8 citations

Jeffrey S. Chamberlain, Guy L. Odom, Glen B. Banks

Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease

Molecular Therapy — Methods & Clinical Development(2020)10.1016/j.omtm.2020.07.004

N/A

0DataRank · unranked

15 citations

Nathalie Clément, Lakmini P. Wasala, H. T. Yang, Yongping Yue, Keqing Zhang +9 more

Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles

Molecular Therapy(2020)10.1016/j.ymthe.2020.11.003

N/A

0DataRank · unranked

25 citations

Hichem Tasfaout, Stephen D. Hauschka, Jeffrey S. Chamberlain, Niclas E. Bengtsson

Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model

JCI Insight(2021)10.1172/jci.insight.146511

N/A

0DataRank · unranked

29 citations

Lisa E. Dorn, Jeovanna Lowe, Megan D. Gertzen, Pierce Ciccone, Neha Rastogi +5 more

Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal model

Molecular Therapy(2022)10.1016/j.ymthe.2022.02.003

N/A

0DataRank · unranked

12 citations

Julie M. Crudele, Jordan M. Klaiman, Christine L. Halbert, Stephen D. Hauschka, Jeffrey S. Chamberlain +1 more

Critical role of PCYT2 in muscle health and aging

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.02.482658

N/A

0DataRank · unranked

4 citations

Kareem Elsayad, Erdinç Sezgin, Erika Koitai, Ferenc Torma, Michael Orthofer +33 more

Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy

Science Translational Medicine(2023)10.1126/scitranslmed.abo1815

N/A

0DataRank · unranked

68 citations

Michael W. Lawlor, Thomas J. Conlon, Lee‐Jae Guo, Julie M. Crudele, Eleanor C. Hawkins +26 more

PCYT2-regulated lipid biosynthesis is critical to muscle health and ageing

Nature Metabolism(2023)10.1038/s42255-023-00766-2

N/A

0DataRank · unranked

57 citations

Kareem Elsayad, Erdinç Sezgin, Erika Koitai, Ferenc Torma, Michael Orthofer +33 more

Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials

Human Gene Therapy(2023)10.1089/hum.2022.190

N/A

0DataRank · unranked

33 citations

Melissa A. Robb, Serge Braun, Kristy J. Brown, Olivier Danos, Annie Ganot +9 more

Innate and adaptive AAV-mediated immune responses in a mouse model of Duchenne muscular dystrophy

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.06.002

N/A

0DataRank · unranked

21 citations

Alejandro Espinoza, Courtney S. Young, Feiyang Ma, Philip K. Farahat, Philip L. Felgner +7 more

Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.02.001

N/A

0DataRank · unranked

18 citations

Jeovanna Lowe, Laurel R. Cumby, Lisa E. Dorn, Dana M. Lake, Neha Rastogi +8 more

In vivo selection of synthetic nucleocapsids for tissue targeting

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2306129120

N/A

0DataRank · unranked

8 citations

Halli Benasutti, Meilyn Sylvestre, Gabriel L. Butterfield, Gabriel J. Rocklin, Christian Richardson +14 more

Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle

Skeletal Muscle(2023)10.1186/s13395-023-00325-z

N/A

0DataRank · unranked

9 citations

Estela Kato dos Santos, Renato Ferretti, G. A. Nagana Gowda, Guy L. Odom, Jeffrey S. Chamberlain +2 more

Efficacy and muscle safety assessment of fukutin-related protein gene therapy

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.05.022

N/A

0DataRank · unranked

7 citations

Joseph W. Maricelli, Jane T. Seto, John K. Hall, Christine L. Halbert, Jacqueline Wicki +7 more

Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.17.533157

N/A

0DataRank · unranked

3 citations

Michael J. Petrany, Elena Greenfeld, Leah C. Focke, A. Cramer, Michael A. Whitt +5 more

Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle

Research Square(2023)10.21203/rs.3.rs-3038923/v1

N/A

0DataRank · unranked

1 citations

Estela Kato dos Santos, Renato Ferretti, G. A. Nagana Gowda, Guy L. Odom, Jeffrey S. Chamberlain +2 more

Gene therapy delivered micro-dystrophins co-localize with transgenic utrophin in dystrophic skeletal muscle fibers

Neuromuscular Disorders(2024)10.1016/j.nmd.2024.01.004

N/A

0DataRank · unranked

6 citations

Arden B. Piepho, Dana M. Lake, Laurel R. Cumby, Kaelyn K. Lortz, Jeovanna Lowe +3 more

The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy

Molecular Therapy(2025)10.1016/j.ymthe.2025.03.065

N/A

0DataRank · unranked

29 citations

Hichem Tasfaout, Jeffrey S. Chamberlain, Niclas E. Bengtsson

Genetic strategies for therapy of Duchenne muscular dystrophy

Molecular Therapy — Nucleic Acids(2025)10.1016/j.omtn.2025.102759

N/A

0DataRank · unranked

7 citations

Jeffrey S. Chamberlain, Józef Dulak, Agnieszka Łoboda

Bidirectional role of Costameres in the pathophysiology of mdx skeletal muscles

Human Molecular Genetics(2025)10.1093/hmg/ddaf127

N/A

0DataRank · unranked

1 citations

Darren Bisset, Jeffrey S. Chamberlain, Glen B. Banks

Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle

JCI Insight(2025)10.1172/jci.insight.197759

N/A

0DataRank · unranked

0 citations

Theodore R. Reyes, Jeffrey S. Chamberlain, James M. Ervasti, Hichem Tasfaout, Erynn E. Johnson